The development of the press and breath pMDI, Asmair®, will be completed over the next few weeks. As part of the final technical adjustments and interviews with users and clients, B&O Medicom has also developed two alternative industrial designs that will be promoted later this year. These designs, which share the same single incremental dose counter principle, confirm B&O Medicom’s continuous commitment to non-stigmatising, user-friendly and robust inhalation devices solutions. The new Asmair® designs can be presented in confidence.

Further information about Bang & Olufsen Medicom’s inhaler port folio here.

Return to main headlines